| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 CALCRL CRHR2 OR4L1 HRH3 OR11H6 | 7.55e-13 | 884 | 61 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R EPHA6 OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 CALCRL SLC22A17 CRHR2 OR4L1 HRH3 OR11H6 | 2.76e-11 | 1353 | 61 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | transporter activity | SLC22A9 TRPC7 KCNU1 TRPM7 ATP13A1 ATP8A2 TRPC3 TRPC6 SLC22A10 SLC49A4 CYB561D1 KCNK5 SLC34A3 TMC5 SLC30A1 SLC23A2 ABCA9 SLC22A17 SLC16A10 | 4.70e-09 | 1289 | 61 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC22A9 TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 SLC22A10 SLC49A4 CYB561D1 KCNK5 SLC34A3 TMC5 SLC30A1 SLC23A2 ABCA9 SLC22A17 SLC16A10 | 7.86e-09 | 1180 | 61 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 1.33e-06 | 465 | 61 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 3.21e-06 | 133 | 61 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 4.31e-06 | 140 | 61 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 5.85e-06 | 12 | 61 | 3 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 9.64e-06 | 14 | 61 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC22A9 ATP13A1 SLC22A10 CYB561D1 SLC34A3 SLC30A1 SLC23A2 ABCA9 SLC16A10 | 1.35e-05 | 477 | 61 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 1.85e-05 | 627 | 61 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 KCNK5 SLC34A3 TMC5 SLC30A1 SLC23A2 | 2.46e-05 | 793 | 61 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 3.01e-05 | 664 | 61 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 7.53e-05 | 27 | 61 | 3 | GO:0004683 | |
| GeneOntologyMolecularFunction | short-chain fatty acid transmembrane transporter activity | 9.13e-05 | 5 | 61 | 2 | GO:0015636 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPC7 KCNU1 TRPM7 ATP13A1 TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 9.14e-05 | 758 | 61 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 2.66e-04 | 41 | 61 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | hormone binding | 2.78e-04 | 103 | 61 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.82e-04 | 296 | 61 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.84e-04 | 459 | 61 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 5.94e-04 | 12 | 61 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.17e-04 | 343 | 61 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 6.36e-04 | 55 | 61 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.53e-04 | 129 | 61 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | channel activity | 1.07e-03 | 525 | 61 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.08e-03 | 526 | 61 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.17e-03 | 151 | 61 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.36e-03 | 18 | 61 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | amine binding | 1.86e-03 | 21 | 61 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.99e-03 | 431 | 61 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.04e-03 | 22 | 61 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 2.23e-03 | 23 | 61 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.64e-03 | 90 | 61 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.04e-03 | 196 | 61 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 3.07e-03 | 27 | 61 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.69e-03 | 207 | 61 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.75e-03 | 208 | 61 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | alcohol binding | 3.76e-03 | 102 | 61 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 4.03e-03 | 31 | 61 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.00e-03 | 363 | 61 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 8.00e-03 | 44 | 61 | 2 | GO:0046915 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 9.46e-03 | 48 | 61 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | protein kinase activity | 9.84e-03 | 600 | 61 | 6 | GO:0004672 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 9.84e-03 | 49 | 61 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 1.02e-02 | 50 | 61 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 1.06e-02 | 51 | 61 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.16e-02 | 446 | 61 | 5 | GO:0004674 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.23e-02 | 293 | 61 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.35e-02 | 301 | 61 | 4 | GO:0022853 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 CAMK2B FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 CALCRL CRHR2 OR4L1 HRH3 OR11H6 | 2.08e-10 | 1395 | 61 | 21 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC22A9 TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2B CAMK2D CAMK2G TRPC3 TRPC6 SLC22A10 KCNK5 SLC34A3 CALCRL TMC5 SLC30A1 SLC23A2 SLC22A17 CRHR2 HRH3 | 1.15e-09 | 1374 | 61 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | GPBAR1 VIPR2 ADRA1B HTR1F FFAR3 GPR42 MC1R CALCRL CRHR2 HRH3 | 1.09e-08 | 286 | 61 | 10 | GO:0007188 |
| GeneOntologyBiologicalProcess | metal ion transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2B CAMK2D CAMK2G TRPC3 TRPC6 KCNK5 SLC34A3 CALCRL SLC30A1 SLC23A2 SLC22A17 CRHR2 | 2.14e-08 | 1000 | 61 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2B CAMK2D CAMK2G TRPC3 TRPC6 KCNK5 SLC34A3 CALCRL SLC30A1 SLC23A2 SLC22A17 CRHR2 | 1.60e-07 | 1157 | 61 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 9.86e-07 | 26 | 61 | 4 | GO:0014061 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 1.34e-06 | 28 | 61 | 4 | GO:0048243 | |
| GeneOntologyBiologicalProcess | calcium ion transport | TRPC7 TRPM7 CAMK2B CAMK2D CAMK2G TRPC3 TRPC6 CALCRL SLC30A1 CRHR2 | 2.24e-06 | 509 | 61 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | norepinephrine transport | 4.74e-06 | 38 | 61 | 4 | GO:0015874 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 2.58e-05 | 3 | 61 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 3.18e-05 | 61 | 61 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | hormone transport | 3.87e-05 | 432 | 61 | 8 | GO:0009914 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 3.98e-05 | 129 | 61 | 5 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 4.57e-05 | 323 | 61 | 7 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 4.62e-05 | 67 | 61 | 4 | GO:0050433 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 5.14e-05 | 4 | 61 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | ADRA1B TRPC7 TRPM7 ATP13A1 FFAR3 CAMK2D GPR42 TRPC3 TRPC6 SLC34A3 SLC30A1 SLC22A17 CRHR2 | 5.94e-05 | 1249 | 61 | 13 | GO:0048878 |
| GeneOntologyBiologicalProcess | organic cation transport | 6.94e-05 | 145 | 61 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 7.22e-05 | 922 | 61 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | TRPC7 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 SLC34A3 SLC30A1 SLC22A17 | 8.33e-05 | 622 | 61 | 9 | GO:0098771 |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 8.55e-05 | 5 | 61 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 KCNK5 SLC34A3 TMC5 SLC30A1 SLC23A2 | 8.73e-05 | 1115 | 61 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 8.74e-05 | 942 | 61 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | catecholamine secretion | 8.81e-05 | 79 | 61 | 4 | GO:0050432 | |
| GeneOntologyBiologicalProcess | signal release | 1.20e-04 | 653 | 61 | 9 | GO:0023061 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.23e-04 | 86 | 61 | 4 | GO:0007193 | |
| GeneOntologyBiologicalProcess | positive regulation of neuronal action potential | 1.28e-04 | 6 | 61 | 2 | GO:1904457 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | TRPC7 KCNU1 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 KCNK5 SLC34A3 SLC30A1 SLC23A2 | 1.72e-04 | 1017 | 61 | 11 | GO:0098660 |
| GeneOntologyBiologicalProcess | catecholamine transport | 1.88e-04 | 96 | 61 | 4 | GO:0051937 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | TRPC7 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 SLC34A3 SLC30A1 SLC22A17 CRHR2 | 2.08e-04 | 866 | 61 | 10 | GO:0055082 |
| GeneOntologyBiologicalProcess | hormone secretion | 2.34e-04 | 420 | 61 | 7 | GO:0046879 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 2.46e-04 | 103 | 61 | 4 | GO:0048814 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 2.85e-04 | 577 | 61 | 8 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of system process | 2.88e-04 | 734 | 61 | 9 | GO:0044057 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of cardiac muscle | 3.06e-04 | 9 | 61 | 2 | GO:1901897 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by chemical signal | 3.06e-04 | 9 | 61 | 2 | GO:0003062 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 3.43e-04 | 317 | 61 | 6 | GO:0090257 | |
| GeneOntologyBiologicalProcess | single fertilization | 3.82e-04 | 209 | 61 | 5 | GO:0007338 | |
| GeneOntologyBiologicalProcess | monoamine transport | 3.87e-04 | 116 | 61 | 4 | GO:0015844 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 4.18e-04 | 611 | 61 | 8 | GO:0030003 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 4.26e-04 | 214 | 61 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 4.71e-04 | 622 | 61 | 8 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 5.14e-04 | 125 | 61 | 4 | GO:0051952 | |
| GeneOntologyBiologicalProcess | regulation of serotonin secretion | 5.57e-04 | 12 | 61 | 2 | GO:0014062 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | TRPC7 TRPM7 ATP13A1 CAMK2D TRPC3 TRPC6 SLC34A3 SLC30A1 SLC22A17 CRHR2 | 5.60e-04 | 981 | 61 | 10 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 6.11e-04 | 493 | 61 | 7 | GO:0010959 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 6.49e-04 | 133 | 61 | 4 | GO:0043502 | |
| GeneOntologyBiologicalProcess | positive regulation of transmission of nerve impulse | 6.57e-04 | 13 | 61 | 2 | GO:0051971 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 6.61e-04 | 359 | 61 | 6 | GO:0006874 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 6.77e-04 | 237 | 61 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 6.77e-04 | 237 | 61 | 5 | GO:1905475 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 7.03e-04 | 239 | 61 | 5 | GO:0051048 | |
| GeneOntologyBiologicalProcess | amine transport | 7.25e-04 | 137 | 61 | 4 | GO:0015837 | |
| GeneOntologyBiologicalProcess | negative regulation of insulin secretion | 8.22e-04 | 62 | 61 | 3 | GO:0046676 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 8.45e-04 | 249 | 61 | 5 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 8.76e-04 | 684 | 61 | 8 | GO:0010817 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 8.81e-04 | 15 | 61 | 2 | GO:0098908 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 1.00e-03 | 389 | 61 | 6 | GO:0055074 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.02e-03 | 150 | 61 | 4 | GO:0050773 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 1.03e-03 | 67 | 61 | 3 | GO:0050775 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 1.06e-03 | 705 | 61 | 8 | GO:0055080 | |
| GeneOntologyBiologicalProcess | fertilization | 1.08e-03 | 263 | 61 | 5 | GO:0009566 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.12e-03 | 547 | 61 | 7 | GO:0003012 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 1.12e-03 | 69 | 61 | 3 | GO:0010770 | |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 1.17e-03 | 70 | 61 | 3 | GO:0045776 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 1.19e-03 | 717 | 61 | 8 | GO:0050801 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 1.24e-03 | 722 | 61 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | positive regulation of action potential | 1.28e-03 | 18 | 61 | 2 | GO:0045760 | |
| GeneOntologyBiologicalProcess | striated muscle adaptation | 1.32e-03 | 73 | 61 | 3 | GO:0014888 | |
| GeneOntologyBiologicalProcess | negative regulation of peptide hormone secretion | 1.32e-03 | 73 | 61 | 3 | GO:0090278 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.35e-03 | 162 | 61 | 4 | GO:0007631 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 1.41e-03 | 164 | 61 | 4 | GO:0043500 | |
| GeneOntologyBiologicalProcess | regulation of relaxation of muscle | 1.42e-03 | 19 | 61 | 2 | GO:1901077 | |
| GeneOntologyBiologicalProcess | serotonin secretion | 1.42e-03 | 19 | 61 | 2 | GO:0001820 | |
| GeneOntologyBiologicalProcess | negative regulation of peptide secretion | 1.43e-03 | 75 | 61 | 3 | GO:0002792 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 1.58e-03 | 20 | 61 | 2 | GO:0014733 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.60e-03 | 582 | 61 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 1.65e-03 | 171 | 61 | 4 | GO:0043271 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.71e-03 | 432 | 61 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | relaxation of cardiac muscle | 1.74e-03 | 21 | 61 | 2 | GO:0055119 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion import | 1.74e-03 | 21 | 61 | 2 | GO:0090281 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.78e-03 | 81 | 61 | 3 | GO:0098900 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.87e-03 | 298 | 61 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | export from cell | KISS1R FFAR3 GPR42 CAMK2G VAMP7 KCNK5 SLC30A1 CRHR2 HRH3 SLC16A10 | 1.91e-03 | 1153 | 61 | 10 | GO:0140352 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.98e-03 | 84 | 61 | 3 | GO:0051480 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.09e-03 | 23 | 61 | 2 | GO:0098664 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 2.13e-03 | 612 | 61 | 7 | GO:0010975 | |
| GeneOntologyBiologicalProcess | heart process | 2.19e-03 | 309 | 61 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.40e-03 | 802 | 61 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 2.46e-03 | 191 | 61 | 4 | GO:0007189 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 2.48e-03 | 465 | 61 | 6 | GO:0007608 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 2.65e-03 | 815 | 61 | 8 | GO:0043408 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.73e-03 | 819 | 61 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 2.76e-03 | 326 | 61 | 5 | GO:1903522 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 2.81e-03 | 198 | 61 | 4 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.88e-03 | 826 | 61 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | blood circulation | 2.93e-03 | 648 | 61 | 7 | GO:0008015 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 2.35e-07 | 5 | 61 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 3.07e-04 | 45 | 61 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | varicosity | 8.58e-04 | 15 | 61 | 2 | GO:0043196 | |
| MousePheno | abnormal sympathetic neuron innervation pattern | 3.46e-05 | 3 | 48 | 2 | MP:0009284 | |
| MousePheno | abnormal sympathetic neuron physiology | 6.90e-05 | 4 | 48 | 2 | MP:0009253 | |
| Domain | 7tm_1 | GPBAR1 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 OR4L1 HRH3 OR11H6 | 3.19e-11 | 677 | 61 | 17 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPBAR1 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 OR4L1 HRH3 OR11H6 | 3.84e-11 | 685 | 61 | 17 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPBAR1 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 OR4L1 HRH3 OR11H6 | 4.40e-11 | 691 | 61 | 17 | PS50262 |
| Domain | GPCR_Rhodpsn | GPBAR1 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 GPR42 OR6Q1 MRGPRE GPR85 MC1R OR4K5 OR4L1 HRH3 OR11H6 | 4.50e-11 | 692 | 61 | 17 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | GPBAR1 CYSLTR2 ADRA1B HTR1F KISS1R OR4K17 OR11H4 FFAR3 OR6Q1 MRGPRE GPR85 MC1R OR4K5 OR4L1 HRH3 OR11H6 | 2.84e-10 | 670 | 61 | 16 | IPR017452 |
| Domain | CaMKII_AD | 1.32e-07 | 4 | 61 | 3 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.32e-07 | 4 | 61 | 3 | IPR013543 | |
| Domain | TRP_dom | 6.58e-07 | 6 | 61 | 3 | IPR013555 | |
| Domain | TRP_2 | 6.58e-07 | 6 | 61 | 3 | PF08344 | |
| Domain | TRPC_channel | 1.15e-06 | 7 | 61 | 3 | IPR002153 | |
| Domain | TRP_channel | 5.37e-06 | 11 | 61 | 3 | IPR004729 | |
| Domain | - | 9.26e-06 | 13 | 61 | 3 | 3.10.450.50 | |
| Domain | NTF2-like_dom | 1.47e-05 | 15 | 61 | 3 | IPR032710 | |
| Domain | MFS | 2.71e-05 | 108 | 61 | 5 | PS50850 | |
| Domain | Ion_trans_dom | 3.51e-05 | 114 | 61 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.51e-05 | 114 | 61 | 5 | PF00520 | |
| Domain | GPR40-rel_orph | 6.27e-05 | 4 | 61 | 2 | IPR013312 | |
| Domain | HormR | 7.24e-05 | 25 | 61 | 3 | SM00008 | |
| Domain | MFS_dom | 7.60e-05 | 134 | 61 | 5 | IPR020846 | |
| Domain | HRM | 1.02e-04 | 28 | 61 | 3 | PF02793 | |
| Domain | MFS | 1.17e-04 | 77 | 61 | 4 | IPR011701 | |
| Domain | MFS_1 | 1.17e-04 | 77 | 61 | 4 | PF07690 | |
| Domain | GPCR_2_secretin-like_CS | 1.85e-04 | 34 | 61 | 3 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.00e-04 | 40 | 61 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.00e-04 | 40 | 61 | 3 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 3.00e-04 | 40 | 61 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.82e-04 | 50 | 61 | 3 | PS00650 | |
| Domain | 7tm_2 | 5.82e-04 | 50 | 61 | 3 | PF00002 | |
| Domain | GPCR_2-like | 9.94e-04 | 60 | 61 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 9.94e-04 | 60 | 61 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.04e-03 | 61 | 61 | 3 | PS50261 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.49e-03 | 69 | 61 | 3 | IPR020636 | |
| Domain | Olfact_rcpt | 1.75e-03 | 393 | 61 | 6 | IPR000725 | |
| Domain | - | 4.89e-03 | 32 | 61 | 2 | 2.70.150.10 | |
| Domain | - | 4.89e-03 | 32 | 61 | 2 | 3.40.1110.10 | |
| Domain | ATPase_P-typ_cyto_domN | 5.83e-03 | 35 | 61 | 2 | IPR023299 | |
| Domain | 7TM_GPCR_Srsx | 5.87e-03 | 112 | 61 | 3 | SM01381 | |
| Domain | Sugar_tr | 6.15e-03 | 36 | 61 | 2 | PF00083 | |
| Domain | MFS_sugar_transport-like | 6.15e-03 | 36 | 61 | 2 | IPR005828 | |
| Domain | ATPase_P-typ_P_site | 6.15e-03 | 36 | 61 | 2 | IPR018303 | |
| Domain | P_typ_ATPase | 6.15e-03 | 36 | 61 | 2 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 6.15e-03 | 36 | 61 | 2 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 6.49e-03 | 37 | 61 | 2 | IPR008250 | |
| Domain | E1-E2_ATPase | 6.49e-03 | 37 | 61 | 2 | PF00122 | |
| Domain | Protein_kinase_ATP_BS | 7.87e-03 | 379 | 61 | 5 | IPR017441 | |
| Domain | Kinase-like_dom | 8.36e-03 | 542 | 61 | 6 | IPR011009 | |
| Pathway | WP_GPCRS_NONODORANT | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R FFAR3 GPR42 MC1R CALCRL CRHR2 HRH3 | 7.89e-11 | 266 | 49 | 12 | MM15843 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPBAR1 VIPR2 CYSLTR2 ADRA1B TRPC7 HTR1F KISS1R CAMK2B FFAR3 CAMK2D CAMK2G TRPC3 TRPC6 MC1R CALCRL CRHR2 HRH3 | 8.55e-11 | 702 | 49 | 17 | M746 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPBAR1 VIPR2 CYSLTR2 ADRA1B TRPC7 HTR1F KISS1R FFAR3 GPR42 TRPC3 TRPC6 MC1R CALCRL CRHR2 HRH3 | 2.59e-09 | 646 | 49 | 15 | MM14962 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 8.03e-09 | 176 | 49 | 9 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.13e-08 | 183 | 49 | 9 | M997 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R FFAR3 GPR42 MC1R CALCRL CRHR2 HRH3 | 1.85e-08 | 430 | 49 | 12 | MM15160 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC7 TRPM7 ATP13A1 CAMK2B ATP8A2 CAMK2D CAMK2G TRPC3 TRPC6 SLC34A3 SLC30A1 ABCA9 SLC22A17 SLC16A10 | 4.62e-08 | 681 | 49 | 14 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | TRPC7 TRPM7 ATP13A1 CAMK2B ATP8A2 CAMK2D CAMK2G TRPC3 TRPC6 SLC34A3 SLC30A1 ABCA9 SLC22A17 SLC16A10 | 1.21e-07 | 736 | 49 | 14 | M27287 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.40e-07 | 272 | 49 | 9 | M13380 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPBAR1 VIPR2 CYSLTR2 ADRA1B HTR1F KISS1R FFAR3 MC1R CALCRL CRHR2 HRH3 | 4.02e-07 | 463 | 49 | 11 | M507 |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 5.67e-07 | 210 | 49 | 8 | MM15043 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.26e-06 | 55 | 49 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.50e-06 | 57 | 49 | 5 | MM15643 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.84e-06 | 333 | 49 | 9 | MM14963 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.48e-06 | 28 | 49 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.48e-06 | 28 | 49 | 4 | M27241 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.82e-06 | 260 | 49 | 8 | M39397 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 4.66e-06 | 10 | 49 | 3 | M27330 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.66e-06 | 10 | 49 | 3 | M26910 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 6.54e-06 | 389 | 49 | 9 | M14091 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 9.22e-06 | 217 | 49 | 7 | M18437 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.10e-05 | 13 | 49 | 3 | MM14553 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.40e-05 | 14 | 49 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 1.40e-05 | 14 | 49 | 3 | M47388 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.62e-05 | 330 | 49 | 8 | M18334 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.63e-05 | 157 | 49 | 6 | M4904 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.74e-05 | 15 | 49 | 3 | M47385 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.14e-05 | 16 | 49 | 3 | M26945 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.59e-05 | 17 | 49 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 3.68e-05 | 19 | 49 | 3 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 3.68e-05 | 19 | 49 | 3 | MM15473 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 4.32e-05 | 20 | 49 | 3 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 5.02e-05 | 21 | 49 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 5.02e-05 | 21 | 49 | 3 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 5.80e-05 | 22 | 49 | 3 | MM15104 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 6.60e-05 | 63 | 49 | 4 | M27862 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 6.66e-05 | 23 | 49 | 3 | M47512 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 6.66e-05 | 23 | 49 | 3 | MM14953 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 6.66e-05 | 23 | 49 | 3 | M27949 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 7.59e-05 | 24 | 49 | 3 | MM15992 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.59e-05 | 24 | 49 | 3 | M47509 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 7.59e-05 | 24 | 49 | 3 | M39643 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.60e-05 | 25 | 49 | 3 | M47511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 8.60e-05 | 25 | 49 | 3 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.09e-04 | 27 | 49 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.09e-04 | 27 | 49 | 3 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.22e-04 | 28 | 49 | 3 | M924 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M47508 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.22e-04 | 28 | 49 | 3 | M837 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.33e-04 | 143 | 49 | 5 | MM15055 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.35e-04 | 29 | 49 | 3 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.66e-04 | 31 | 49 | 3 | M7223 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.82e-04 | 32 | 49 | 3 | M27455 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.82e-04 | 32 | 49 | 3 | M27900 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.00e-04 | 33 | 49 | 3 | M39875 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.19e-04 | 34 | 49 | 3 | M27556 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.39e-04 | 35 | 49 | 3 | MM15109 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.39e-04 | 35 | 49 | 3 | MM15271 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.82e-04 | 37 | 49 | 3 | M749 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.06e-04 | 38 | 49 | 3 | M27255 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE | 3.27e-04 | 8 | 49 | 2 | M10546 | |
| Pathway | PID_IFNG_PATHWAY | 3.56e-04 | 40 | 49 | 3 | M161 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.69e-04 | 178 | 49 | 5 | M2890 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.81e-04 | 99 | 49 | 4 | MM14910 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.83e-04 | 41 | 49 | 3 | M512 | |
| Pathway | KEGG_MELANOGENESIS | 4.11e-04 | 101 | 49 | 4 | M7761 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 4.12e-04 | 42 | 49 | 3 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 4.12e-04 | 42 | 49 | 3 | MM14971 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 4.42e-04 | 103 | 49 | 4 | MM15196 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 4.73e-04 | 44 | 49 | 3 | M27934 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 4.73e-04 | 44 | 49 | 3 | M39845 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.73e-04 | 44 | 49 | 3 | M875 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.93e-04 | 106 | 49 | 4 | M27200 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 5.05e-04 | 45 | 49 | 3 | M27623 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 5.75e-04 | 47 | 49 | 3 | M39531 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.64e-04 | 54 | 49 | 3 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.64e-04 | 54 | 49 | 3 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 8.64e-04 | 54 | 49 | 3 | M26911 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.06e-03 | 130 | 49 | 4 | M27454 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.18e-03 | 60 | 49 | 3 | MM14964 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 1.48e-03 | 65 | 49 | 3 | M38994 | |
| Pathway | KEGG_GLIOMA | 1.48e-03 | 65 | 49 | 3 | M1835 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.67e-03 | 147 | 49 | 4 | MM15854 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.83e-03 | 70 | 49 | 3 | M3115 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.83e-03 | 70 | 49 | 3 | MM14984 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.84e-03 | 151 | 49 | 4 | M39329 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 2.15e-03 | 74 | 49 | 3 | M48080 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 2.24e-03 | 75 | 49 | 3 | M39568 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.32e-03 | 76 | 49 | 3 | MM15051 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.55e-03 | 165 | 49 | 4 | MM15026 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 2.88e-03 | 82 | 49 | 3 | M27626 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.08e-03 | 417 | 49 | 6 | M4072 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.30e-03 | 86 | 49 | 3 | M916 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 3.41e-03 | 87 | 49 | 3 | M12467 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 3.75e-03 | 90 | 49 | 3 | M6467 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.91e-03 | 186 | 49 | 4 | MM15994 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.99e-03 | 92 | 49 | 3 | MM14951 | |
| Pathway | WP_ERBB_SIGNALING | 3.99e-03 | 92 | 49 | 3 | M39715 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 4.24e-03 | 94 | 49 | 3 | M797 | |
| Pubmed | 1.78e-09 | 10 | 61 | 4 | 27177420 | ||
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 5.13e-09 | 3 | 61 | 3 | 9060999 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 10819240 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 20844140 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 28526717 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 30017393 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 22566504 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 2.05e-08 | 4 | 61 | 3 | 17367784 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 10381553 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 11889801 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 11013247 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 5.12e-08 | 5 | 61 | 3 | 16436603 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 18218981 | ||
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 5.12e-08 | 5 | 61 | 3 | 20351294 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 21209221 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 21261756 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 14722083 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 8.86e-08 | 24 | 61 | 4 | 33884443 | |
| Pubmed | Multiple kinases regulate mafA expression in the pancreatic beta cell line MIN6. | 1.02e-07 | 6 | 61 | 3 | 18948074 | |
| Pubmed | 1.05e-07 | 25 | 61 | 4 | 16382100 | ||
| Pubmed | 1.46e-07 | 27 | 61 | 4 | 16460286 | ||
| Pubmed | 1.56e-07 | 70 | 61 | 5 | 12036966 | ||
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 1.79e-07 | 7 | 61 | 3 | 15757897 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 38835669 | ||
| Pubmed | Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II. | 1.79e-07 | 7 | 61 | 3 | 9115241 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 32350291 | ||
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 1.79e-07 | 7 | 61 | 3 | 15336983 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 36257322 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 11264466 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 2.86e-07 | 8 | 61 | 3 | 12032305 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 15199065 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 20668654 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 25471572 | ||
| Pubmed | 3.37e-07 | 33 | 61 | 4 | 19834762 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 11290752 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 17480026 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 12660151 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.04e-07 | 38 | 61 | 4 | 30786075 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 28361052 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 6.11e-07 | 10 | 61 | 3 | 18989690 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 19776387 | ||
| Pubmed | 7.50e-07 | 179 | 61 | 6 | 18577758 | ||
| Pubmed | 1.10e-06 | 44 | 61 | 4 | 19322198 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 8615909 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 12815021 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 8665664 | ||
| Pubmed | 1.43e-06 | 200 | 61 | 6 | 18240029 | ||
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 22051675 | ||
| Pubmed | 1.84e-06 | 14 | 61 | 3 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 2.30e-06 | 15 | 61 | 3 | 14622581 | |
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 9481670 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 2.83e-06 | 16 | 61 | 3 | 19679677 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20399779 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25637492 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23800468 | ||
| Pubmed | Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42. | 3.03e-06 | 2 | 61 | 2 | 19630535 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 30478340 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28105583 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 38040866 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15294044 | ||
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 3.03e-06 | 2 | 61 | 2 | 9930701 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22724068 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35408893 | ||
| Pubmed | FFAR3 modulates insulin secretion and global gene expression in mouse islets. | 3.03e-06 | 2 | 61 | 2 | 26091414 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10693762 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35051376 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27550964 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 38597448 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23110765 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 3.03e-06 | 2 | 61 | 2 | 35858247 | |
| Pubmed | The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. | 3.03e-06 | 2 | 61 | 2 | 26522986 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22506074 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32073900 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31619570 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22306362 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 14722361 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19749484 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27664183 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 29992531 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24453217 | ||
| Pubmed | CaMK-II oligomerization potential determined using CFP/YFP FRET. | 3.03e-06 | 2 | 61 | 2 | 16185778 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9368034 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26567004 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24748202 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 3.03e-06 | 2 | 61 | 2 | 20190513 | |
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 3.03e-06 | 2 | 61 | 2 | 34303021 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23529130 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 36362376 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 33333171 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25124496 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25213992 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26260360 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 37019194 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27861908 | ||
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 3.03e-06 | 2 | 61 | 2 | 35805125 | |
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 3.03e-06 | 2 | 61 | 2 | 12970363 | |
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 3.03e-06 | 2 | 61 | 2 | 29700422 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25193973 | ||
| Interaction | TRPC7 interactions | 3.82e-07 | 6 | 55 | 3 | int:TRPC7 | |
| Interaction | CIBAR2 interactions | 6.68e-07 | 7 | 55 | 3 | int:CIBAR2 | |
| Interaction | CAMK2N1 interactions | 2.28e-06 | 10 | 55 | 3 | int:CAMK2N1 | |
| Interaction | FAM163B interactions | 1.52e-05 | 18 | 55 | 3 | int:FAM163B | |
| Interaction | LTC4S interactions | 2.12e-05 | 20 | 55 | 3 | int:LTC4S | |
| Interaction | ITPR3 interactions | 2.32e-05 | 211 | 55 | 6 | int:ITPR3 | |
| Interaction | SERINC1 interactions | 2.62e-05 | 63 | 55 | 4 | int:SERINC1 | |
| Interaction | AGPAT5 interactions | 4.45e-05 | 72 | 55 | 4 | int:AGPAT5 | |
| Interaction | MAP10 interactions | 6.68e-05 | 29 | 55 | 3 | int:MAP10 | |
| Interaction | PDE4A interactions | 7.41e-05 | 30 | 55 | 3 | int:PDE4A | |
| Interaction | TRPC3 interactions | 9.90e-05 | 33 | 55 | 3 | int:TRPC3 | |
| Interaction | TMEM60 interactions | 1.16e-04 | 92 | 55 | 4 | int:TMEM60 | |
| Interaction | CAMK2N2 interactions | 1.52e-04 | 7 | 55 | 2 | int:CAMK2N2 | |
| Interaction | DNAL4 interactions | 1.64e-04 | 39 | 55 | 3 | int:DNAL4 | |
| Interaction | PLCB3 interactions | 1.67e-04 | 101 | 55 | 4 | int:PLCB3 | |
| Interaction | SLC41A1 interactions | 1.77e-04 | 40 | 55 | 3 | int:SLC41A1 | |
| Interaction | SHISA6 interactions | 2.20e-04 | 43 | 55 | 3 | int:SHISA6 | |
| Interaction | SH2D1A interactions | 2.52e-04 | 45 | 55 | 3 | int:SH2D1A | |
| Cytoband | 14q11.2 | 1.55e-07 | 180 | 61 | 6 | 14q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 5.43e-06 | 332 | 61 | 6 | chr14q11 | |
| Cytoband | 19p13.11 | 1.30e-04 | 73 | 61 | 3 | 19p13.11 | |
| Cytoband | 19q13.1 | 2.46e-03 | 55 | 61 | 2 | 19q13.1 | |
| GeneFamily | Transient receptor potential cation channels | 7.18e-07 | 28 | 46 | 4 | 249 | |
| GeneFamily | Solute carriers | SLC22A9 SLC22A10 SLC49A4 SLC34A3 SLC30A1 SLC23A2 SLC22A17 SLC16A10 | 6.10e-06 | 395 | 46 | 8 | 752 |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.03e-03 | 78 | 46 | 3 | 262 | |
| GeneFamily | Olfactory receptors, family 11 | 1.55e-03 | 23 | 46 | 2 | 159 | |
| GeneFamily | Olfactory receptors, family 4 | 4.31e-03 | 129 | 46 | 3 | 151 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.94e-06 | 152 | 60 | 5 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-06 | 174 | 60 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.97e-06 | 176 | 60 | 5 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 180 | 60 | 5 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 180 | 60 | 5 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.93e-06 | 184 | 60 | 5 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.93e-06 | 184 | 60 | 5 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.93e-06 | 184 | 60 | 5 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 6.22e-06 | 193 | 60 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 6.54e-06 | 195 | 60 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.22e-06 | 199 | 60 | 5 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-05 | 143 | 60 | 4 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-05 | 143 | 60 | 4 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 162 | 60 | 4 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 162 | 60 | 4 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.25e-05 | 165 | 60 | 4 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 7.77e-05 | 168 | 60 | 4 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-05 | 170 | 60 | 4 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.32e-05 | 171 | 60 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 171 | 60 | 4 | d322cc042a6f4b4aa8ef80ae977edbce9e266d48 | |
| ToppCell | Immune_cells-pro-B|World / Lineage and Cell class | 8.90e-05 | 174 | 60 | 4 | e173adbf5789dfa20f3cbc668efde5f0992ac219 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.72e-05 | 178 | 60 | 4 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.72e-05 | 178 | 60 | 4 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.93e-05 | 179 | 60 | 4 | c815eb9f760fe4ca7a5e49beb224659f0b864f22 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 179 | 60 | 4 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 179 | 60 | 4 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.93e-05 | 179 | 60 | 4 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 180 | 60 | 4 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 181 | 60 | 4 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 60 | 4 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.10e-04 | 184 | 60 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 186 | 60 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 60 | 4 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.25e-04 | 190 | 60 | 4 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 190 | 60 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.35e-04 | 194 | 60 | 4 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.35e-04 | 194 | 60 | 4 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.38e-04 | 195 | 60 | 4 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 1.41e-04 | 196 | 60 | 4 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-04 | 196 | 60 | 4 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 197 | 60 | 4 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 197 | 60 | 4 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-04 | 198 | 60 | 4 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 199 | 60 | 4 | 951c2ea5af4756832c2adcec3ee70a7e36331a4e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 200 | 60 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 200 | 60 | 4 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 200 | 60 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-04 | 200 | 60 | 4 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 200 | 60 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-04 | 200 | 60 | 4 | 6f7ff0533339fcc9d316f2c77334a79c1409ec4f | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Yolk_Sac_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.60e-04 | 78 | 60 | 3 | 35e6b026a7fbef495d0fc620677d3f1495b743fc | |
| Drug | Calcium | GPBAR1 CYSLTR2 ADRA1B TRPC7 KISS1R TRPM7 CAMK2D TRPC3 TRPC6 SLC30A1 SLC23A2 HRH3 | 6.19e-09 | 493 | 61 | 12 | ctd:D002118 |
| Drug | 2-aminoethyl diphenylborinate | 4.83e-08 | 127 | 61 | 7 | CID000001598 | |
| Drug | 1-oleoyl-2-acetylglycerol | 8.14e-06 | 15 | 61 | 3 | ctd:C038237 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.18e-05 | 190 | 61 | 6 | 6807_DN | |
| Drug | GW 7845 | 1.45e-05 | 18 | 61 | 3 | ctd:C401311 | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 6089_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 6611_UP | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; PC3; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 3985_UP | |
| Drug | A0666_sigma | 1.54e-05 | 56 | 61 | 4 | CID000005680 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 1.92e-05 | 568 | 61 | 9 | CID000000806 | |
| Drug | adenosine 3',5'-cyclic phosphate | VIPR2 ADRA1B HTR1F CAMK2B ATP8A2 CAMK2D CAMK2G MC1R CALCRL CRHR2 HRH3 | 2.54e-05 | 907 | 61 | 11 | CID000000274 |
| Drug | SB204741 | 3.56e-05 | 24 | 61 | 3 | CID003277600 | |
| Drug | HF-2035 | 4.04e-05 | 25 | 61 | 3 | CID006439511 | |
| Drug | SB 206553 | 4.55e-05 | 26 | 61 | 3 | CID000005163 | |
| Drug | forskolin from Coleus forskohlii | VIPR2 ADRA1B HTR1F CAMK2B FFAR3 CAMK2D MC1R KCNK5 CALCRL CRHR2 HRH3 | 6.94e-05 | 1013 | 61 | 11 | CID000003413 |
| Drug | BEA 1654 | 7.02e-05 | 5 | 61 | 2 | CID000125354 | |
| Drug | carbachol | 8.49e-05 | 688 | 61 | 9 | CID000002551 | |
| Drug | cimetidine | 1.18e-04 | 179 | 61 | 5 | CID000002756 | |
| Drug | K-II | 1.29e-04 | 96 | 61 | 4 | CID000129400 | |
| Drug | borate | 1.40e-04 | 98 | 61 | 4 | CID000007628 | |
| Drug | aminocyclohexanecarboxylic acid | 1.47e-04 | 7 | 61 | 2 | CID000171560 | |
| Drug | TAS-301 | 1.47e-04 | 7 | 61 | 2 | CID009885087 | |
| Drug | AC1L1H4K | 1.56e-04 | 39 | 61 | 3 | CID000003972 | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.68e-04 | 193 | 61 | 5 | 4173_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 4961_UP | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 6208_UP | |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.77e-04 | 195 | 61 | 5 | 6065_UP | |
| Drug | metoprolol | 1.82e-04 | 105 | 61 | 4 | CID000004171 | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; PC3; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6638_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 6506_UP | |
| Drug | bosentan | 1.89e-04 | 106 | 61 | 4 | CID000104865 | |
| Drug | AC1L9NAZ | 1.90e-04 | 198 | 61 | 5 | CID000449606 | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 3864_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 5289_UP | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 5424_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 2554_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 3895_DN | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 4486_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 3879_DN | |
| Drug | pranlukast | 1.96e-04 | 8 | 61 | 2 | ctd:C047681 | |
| Drug | calcium peroxide | 1.96e-04 | 8 | 61 | 2 | CID000014779 | |
| Drug | 1-oleoyl-2-acetoyl-sn-glycerol | 1.96e-04 | 8 | 61 | 2 | ctd:C520323 | |
| Drug | Dimebon | 1.96e-04 | 8 | 61 | 2 | CID000197033 | |
| Drug | flufenamic acid | 2.03e-04 | 108 | 61 | 4 | CID000003371 | |
| Drug | SC-9 | 2.09e-04 | 43 | 61 | 3 | CID000124172 | |
| Drug | BAPTA | 2.28e-04 | 324 | 61 | 6 | CID000104751 | |
| Disease | heart conduction disease (implicated_via_orthology) | 4.35e-09 | 32 | 57 | 5 | DOID:10273 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.49e-06 | 12 | 57 | 3 | DOID:0050742 (implicated_via_orthology) | |
| Disease | estrogen measurement | 1.63e-04 | 10 | 57 | 2 | EFO_0011007 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 6.14e-04 | 19 | 57 | 2 | EFO_0003100, GO_1902519 | |
| Disease | bowel opening frequency | 1.54e-03 | 30 | 57 | 2 | EFO_0600084 | |
| Disease | eating disorder | 1.75e-03 | 32 | 57 | 2 | EFO_0005203 | |
| Disease | right ventricular systolic volume measurement | 2.09e-03 | 35 | 57 | 2 | EFO_0021815 | |
| Disease | rhinitis (is_marker_for) | 3.59e-03 | 46 | 57 | 2 | DOID:4483 (is_marker_for) | |
| Disease | tryptophan measurement | 4.07e-03 | 49 | 57 | 2 | EFO_0008534 | |
| Disease | mean reticulocyte volume | 4.34e-03 | 799 | 57 | 6 | EFO_0010701 | |
| Disease | Hypertensive disease | 5.96e-03 | 190 | 57 | 3 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAAWYLCLALPVYPA | 196 | Q8N8Q1 | |
| GLILGAFVICWLPFF | 296 | P30939 | |
| FWGILGFPALYTRLP | 341 | Q8IUA7 | |
| TVLPFAGLLYPAWLG | 66 | Q9HD20 | |
| CWLPFFIALPLGSLF | 306 | P35368 | |
| APLCGFPWYLPVHFL | 741 | Q7Z2K6 | |
| WCIGLYNVIFTALPP | 911 | Q9NTI2 | |
| FPFPLGWLGGYLAVL | 366 | Q8N130 | |
| LLGIFFLCWGPFFLH | 246 | Q01726 | |
| FIRGWGLCIFLPFVL | 526 | Q86XR2 | |
| SFCWLIGFLGYPIPI | 156 | Q8NGC9 | |
| CWVGGFLCYPVPIVL | 166 | Q8NGC7 | |
| PLLGVWYFLGLGCLE | 111 | Q567V2 | |
| LLFGLCWGPYVATLL | 231 | Q8TDU6 | |
| WSPPLAPGCYQLLLY | 241 | Q5U4P2 | |
| LLPFQLWCPRPFGTY | 6 | Q6PJ61 | |
| VFYGLFGVPLCLTWI | 116 | O95279 | |
| FGPCIFIYVWPFTIS | 251 | Q8NGD3 | |
| ILFFGPCIFIYIWPF | 251 | Q8NGC6 | |
| FGPCIFIYVWPFSSL | 251 | Q8NH43 | |
| LFLFIGWCIPFPIIV | 226 | Q13324 | |
| LLYPLPGWVLGDFMC | 101 | Q969F8 | |
| FLILGLILYPAGWGC | 146 | Q6ZUX7 | |
| FLWNFPQIYILPGCA | 766 | A8MYU2 | |
| ACWLVGFLTPILPIY | 151 | Q8NGQ2 | |
| FLFCGLPFGIYWLSR | 226 | Q86SM8 | |
| WPLPFILCPLSGFIF | 81 | O15529 | |
| GCVIAELFLGWPLYP | 386 | Q9H422 | |
| CPWYIGLPFIPYLDN | 276 | P15170 | |
| ALLVLWGPIGFLPCF | 91 | Q96SL1 | |
| WPLPFILCPLSGFIF | 81 | O14843 | |
| FCIPLYVPYVLTGRW | 86 | Q9Y5N1 | |
| TFLFLTLWGPYLVAC | 291 | P60893 | |
| YFLGWGFPLIPACIH | 256 | Q16602 | |
| GVILYILLVGYPPFW | 201 | Q13555 | |
| GVILYILLVGYPPFW | 201 | Q13557 | |
| YRIWGFPTPEKLGCI | 1861 | Q9P2P1 | |
| PYVPLWLGCEAGFYV | 341 | Q96FA3 | |
| LQFGFFLPLLTAWPG | 11 | Q9UF33 | |
| ICWGLGIEYTFPPLY | 181 | P82914 | |
| GVILYILLVGYPPFW | 201 | Q13554 | |
| TAPCILFLFYGWPGL | 221 | Q8WUG5 | |
| PLPWIIYGVFPFISG | 496 | Q8IVM8 | |
| LPWIIYGIFPIIGGL | 496 | Q63ZE4 | |
| FPIVYLIIFFWGVLG | 41 | Q9NS75 | |
| PGFLQVCDWLYPLVP | 266 | Q8N0X7 | |
| VPPWYLCIFLGLQHY | 96 | Q9UGH3 | |
| VGPLLYLPEWFLCLF | 246 | Q8IV04 | |
| YVWAFGFSPLQPGLL | 111 | Q8N661 | |
| YQLGEFILLFNPWCP | 131 | O43548 | |
| IYIIVSPLCGGFTWP | 201 | P51809 | |
| PPRRCFLAYLLIGWG | 236 | P41587 | |
| GFPFCPLLLTPVAWG | 476 | Q8TEQ8 | |
| LVWIGIFFCPLLPFI | 786 | Q6UXY8 | |
| GLPFLALIYWFAPCS | 416 | Q9Y210 | |
| YEAGPCWVLYLDPTL | 306 | Q9Y6M5 | |
| CGPGTWLTPFLQAVY | 1066 | Q96QT4 | |
| LGLPFLAIGYWIAPC | 346 | Q13507 | |
| FFLSIPYTCLPVWAG | 171 | Q9BZW5 | |
| GLPFLAIAYWIAPCS | 361 | Q9HCX4 | |
| WAVGIPLALFGYFVP | 296 | Q8TF71 |